Olfactory type G-protein α subunit in striosome-matrix dopamine systems in adult mice

Neuroscience

Volumn 170, Issue 2, 2010, Pages 497-502

  Sako, W ^a,b   Morigaki, R ^a,b   Nagahiro, S ^a,b   Kaji, R ^a,b   Goto, S ^a,b  

^a TOKUSHIMA UNIVERSITY HOSPITAL   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

C Fos; Compartmentalization; DARPP 32; Dopamine D1 receptor; G protein; Striatum

Indexed keywords

ADENYLATE CYCLASE; DOPAMINE 1 RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; OLFACTORY TYPE GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STRIOSOME; WESTERN BLOTTING;

ANIMALS; APOMORPHINE; CORPUS STRIATUM; DOPAMINE; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; GTP-BINDING PROTEIN ALPHA SUBUNITS; MICE; NEURONS; RECEPTORS, DOPAMINE D1; RECEPTORS, OPIOID, MU; SIGNAL TRANSDUCTION; TYROSINE 3-MONOOXYGENASE;

EID: 77956189821     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.06.072     Document Type: Article

References (27)

1. Cai G., Wang H.Y., Friedman E. Increased dopamine receptor signaling and dopamine receptor-G protein coupling in denervated striatum. J Pharmacol Exp Ther 2002, 302:1105-1112.
2. Canales J.J., Graybiel A.M. A measure of striatal function predicts motor stereotypy. Nat Neurosci 2000, 3:377-383.
3. Capper-Loup C., Canales J.J., Kadaba N., Graybiel A.M. Concurrent activation of dopamine D1 and D2 receptors is required to evoke neural and behavioral phenotypes of cocaine sensitization. J Neurosci 2002, 22:6218-6227.
4. Corvol J.C., Muriel M.P., Valjent E., Feger J., Hanoun N., Girault J.A., Hirsch E.C., Herve D. Persistent increase in olfactory type G-protein α subunit levels may underlie D1 receptor functional hypersensitivity in Parkinson's disease. J Neurosci 2004, 24:7007-7014.
5. Corvol J.C., Stundler J.M., Schonn J.S., Girault J.A., Herve D. Galpha(olf) is necessary for coupling D1 and A2a receptors to adenylyl cyclase in the striatum. J Neurochem 2001, 76:1585-1588.
6. Corvol J.C., Valjent E., Pascoli V., Robin A., Stipanovich A., Luedtke R.R., Belluscio L., Girault J.A., Herve D. Quantitative changes in Gαolf protein levels, but not D1 receptor, alter specifically acute responses to psychostimulants. Neuropsychopharmacology 2007, 32:1109-1121.
7. Crittenden J.R., Cantuti-Castvetri I., Saka E., Keller-McGandy C.E., Hernandez L.F., Kett L.R., Young A.B., Standaert D.G., Graybiel A.M. Dysregulation of CalDAG-GEFI and CalDAG-GEFII predicts the severity of motor side-effects induced by anti-parkinsonian therapy. Proc Natl Acad Sci U S A 2009, 106:2892-2896.
8. Gerfen C.R. The neostriatal mosaic: multiple levels of compartmental organization. Annu Rev Neurosci 1992, 15:285-320.
9. Goto S., Nagahiro S., Kaji R. Striosome-matrix pathology of dystonias: a new hypothesis for dystonia genesis. Dystonia: causes, symptoms and treatment 2010, 1-22. Nova Science Publishers, New York, NY. J. Kurstot, M. Forsstrom (Eds.).
10. Granado N., Escobedo I., O'shea E., Colado M.I., Moratalla R. Early loss of dopaminergic terminals in striosomes after MDMA administration to mice. Synapse 2008, 62:80-84.
11. Graybiel A.M. Correspondence between the dopamine islands and striosomes of the mammalian striatum. Neuroscience 1984, 13:1157-1187.
12. Graybiel A.M. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci 1990, 13:244-254.
13. Graybiel A.M. Habits, rituals, and the evaluative brain. Annu Rev Neurosci 2008, 31:359-387.
14. Graybiel A.M., Canales J.J., Capper-Loup C. Levodopa-induced dyskinesias and dopamine-dependent stereotypies: a new hypothesis. Trends Neurosci 2000, 23(Suppl 10):S71-S77.
15. Graybiel A.M., Ragsdale C.W. Histochemically distinct compartments in the striatum of human, monkey and cat demonstrated by acetylthiocholinesterase staining. Proc Natl Acad Sci U S A 1978, 75:5723-5726.
16. Greengard P. The neurobiology of slow synaptic transmission. Science 2001, 294:1024-1030.
17. Herve D., Levi-Strauss M., Marey-Semper I., Verney C., Tassin J.P., Glowinski J., Girault J.A. G(olf) and Gs in rat basal ganglia: possible involvement of G(olf) in the coupling of dopamine D1 receptor with adenylyl cyclase. J Neurosci 1993, 13:2237-2248.
18. Herve D., Moine C.L., Corvol J.C., Belluscio L., Ledent C., Fienberg A.A., Jaber M., Studler J.M., Girault J.A. Gαolf levels are regulated by receptor usage and control dopamine and adenosine action in the striatum. J Neurosci 2001, 21:4390-4399.
19. Iravani M.M., Syed E., Jackson M.J., Johnston L.C., Smith L.A., Jenner P. A modified MPTP treatment regime produces reproducible partial nigrostriatal lesions in common marmosets. Eur J Neurosci 2005, 21:841-854.
20. Kim D.S., Froelick G.J., Palmiter R.D. Dopamine-dependent desensitization of dopaminergic signaling in the developing mouse striatum. J Neurosci 2002, 22:9841-9849.
21. Marcotte E.R., Chugh A., Barlas C., Mishra R.K. Differential regulation of striatal G protein levels following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration in C57 BL/6 mice. Neurosci Lett 2001, 306:21-24.
22. Moratalla R., Quinn B., DeLanney L.E., Irwin I., Langston J.W., Graybiel A.M. Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci U S A 1992, 89:3859-3863.
23. Moratalla R., Xu M., Tonegawa S., Graybiel A.M. Cellular response to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor. Proc Natl Acad Sci U S A 1996, 93:14928-14933.
24. Sakagami H., Sawamura Y., Kondo H. Synchronous patchy pattern of gene expression for adenylyl cyclase and phosphodiesterase but discrete expression for G-protein in developing rat striatum. Brain Res Mol Brain Res 1995, 33:185-191.
25. Sato K., Sumi-Ichinose C., Kaji R., Ikemoto K., Nomura T., Nagatsu I., Ichinose H., Ito M., Sako W., Nagahiro S., Graybiel A.M., Goto S. Differential involvement of striosome and matrix dopamine systems in a transgenic model of dopa-responsive dystonia. Proc Natl Acad Sci U S A 2008, 105:12551-12556.
26. Wilson J.S., Turner B.H., Morrow G.D., Hartman P.J. MPTP produces a mosaic-like pattern of terminal degeneration in the caudate nucleus of dog. Brain Res 1987, 423:329-332.
27. Zhuang X., Belluscio L., Hen R. G(olf)α mediates dopamine D1 receptor signaling. J Neurosci 2000, 20:RC91.